EMN vs TRVI · P/E 21, rev $9.38B vs $2.32B cap
Eastman Chemical Company (EMN) versus Trevi Therapeutics Inc (TRVI) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
TRVI does not have a complete income-statement cache yet.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. TRVI currently screens at market cap $2.32B.
Not investment advice. Open the EMN and TRVI stock pages for the full models.
Not investment advice.